Â鶹´«Ã½

Molly Burich, MS, is the Director, Public Policy – Biosimilars and Reimbursement at Boehringer Ingelheim Pharmaceuticals Inc., a role that allows her love of policy and healthcare-related issues to intersect. In her current role, she leads policy efforts at the federal and state levels that impact the franchises of Boehringer Ingelheim, with specific focus on biosimilars, oncology, pipeline products as well as reimbursement across the existing and pipeline portfolio.

Prior to joining Boehringer Ingelheim, Ms. Burich was an Associate Director of Mental Health Policy and Advocacy at Otsuka Product Development and Commercialization, Inc. In that role she focused on key mental health advocacy and policy issues at the state level. Prior to this role, Ms. Burich was a Senior Manager, Federal Government Affairs – Reimbursement and Policy at Otsuka.

Before moving into the pharmaceutical industry, Ms. Burich was also an Assistant Director for Xcenda, an AmerisourceBergen Consulting Services company based in North Carolina. At Xcenda, she focused on reimbursement and health policy issues as they related to strategic reimbursement planning.  Prior to joining Xcenda, Ms. Burich worked for Avalere Health, a health care policy consulting firm based in Washington, DC. In that role, she specialized in reimbursement strategy and product commercialization for new pharmaceuticals and biotechnologies. In addition, she closely monitored ongoing legislative and regulatory changes for pharmaceutical, biotechnology, and medical device companies.

After receiving her BA from Â鶹´«Ã½ in Political Science, Ms. Burich went onto to DePaul University to receive a master of science in public service management with an emphasis in public policy.  

While her career led her to the east coast and away from Colorado, Molly loves to participate in virtual Alumni events and stays in touch with many friends and professors from her Â鶹´«Ã½ Political Science days,  illustrating that not only did the education impact her career, but the relationships formed continue to be present in Molly’s life.